Assignee
CELL PATHWAYS INC
US73 patents
Top patents by PatentIndex Score
US6358992B1Mar 19, 2002
Method of inhibiting neoplastic cells with indole derivatives
CELL PATHWAYS INC125 citations98
US6133271AOct 17, 2000
Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives
CELL PATHWAYS INC92 citations98
US6046206AApr 4, 2000
Method of treating a patient having a precancerous lesions with amide quinazoline derivatives
CELL PATHWAYS INC150 citations98
US6348032B1Feb 19, 2002
Method of inhibiting neoplastic cells with benzimidazole derivatives
CELL PATHWAYS INC117 citations97
US6211177B1Apr 3, 2001
Method for treating neoplasia by exposure to substituted 2-aryl-benzimidazole derivatives
CELL PATHWAYS INC86 citations97
US6410584B1Jun 25, 2002
Method for inhibiting neoplastic cells with indole derivatives
CELL PATHWAYS INC46 citations96
US6200980B1Mar 13, 2001
Method of treating a patient having precancerous lesions with phenyl purinone derivatives
CELL PATHWAYS INC60 citations96
US5948911ASep 7, 1999
Method for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivatives
CELL PATHWAYS INC69 citations96
US5858694AJan 12, 1999
Method for identifying compounds for inhibition of cancerous lesions
CELL PATHWAYS INC60 citations96
US6500610B1Dec 31, 2002
Methods for identifying compounds for inhibiting of neoplastic lesions, and pharmaceutical compositions containing such compounds
CELL PATHWAYS INC22 citations93
US6486155B1Nov 26, 2002
Method of inhibiting neoplastic cells with isoquinoline derivatives
CELL PATHWAYS INC21 citations93
US6369092B1Apr 9, 2002
Method for treating neoplasia by exposure to substituted benzimidazole derivatives
CELL PATHWAYS INC32 citations93
US6232312B1May 15, 2001
Method for treating patient having precancerous lesions with a combination of pyrimidopyrimidine derivatives and esters and amides of substituted indenyl acetic acides
CELL PATHWAYS INC31 citations93
US6034099AMar 7, 2000
Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones
CELL PATHWAYS INC21 citations93
US5942520AAug 24, 1999
Method for inhibiting neoplastic cells by exposure to substituted N-cycloalkylmethyl-1-H-pyrazolo (3,4-B) quinolone-4 amines
CELL PATHWAYS INC27 citations93
US5852035ADec 22, 1998
Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines
CELL PATHWAYS INC28 citations93
US6380206B1Apr 30, 2002
Method of inhibiting neoplastic cells with 4,5-diaminopyrimidine derivatives
CELL PATHWAYS INC35 citations92
US6262059B1Jul 17, 2001
Method of treating a patient having precancerous lesions with quinazoline derivatives
CELL PATHWAYS INC44 citations92
US6180629B1Jan 30, 2001
[4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasia
CELL PATHWAYS INC28 citations92
US6177471B1Jan 23, 2001
Method for treating patients with acne by administering a CGMP-specific PDE inhibitor
CELL PATHWAYS INC66 citations92
US6130053AOct 10, 2000
Method for selecting compounds for inhibition of neoplastic lesions
CELL PATHWAYS INC20 citations92
US6121321ASep 19, 2000
Substituted methoxy benzylidene indenyl acetic and propionic acids for treating patients with precancerous lesions
CELL PATHWAYS INC26 citations92
US6071934AJun 6, 2000
Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesions
CELL PATHWAYS INC25 citations92
US6063818AMay 16, 2000
Substituted benzylidene indenyl formamides, acetamides and propionamides
CELL PATHWAYS INC32 citations92
US6028116AFeb 22, 2000
Substituted condensation products of 1H-indenyl-hydroxyalkanes with aldehydes for neoplasia
CELL PATHWAYS INC29 citations92
US5990117ANov 23, 1999
Method for inhibiting neoplastic cells and related conditions by exposure to quinazoline derivatives
CELL PATHWAYS INC43 citations92
US5965619AOct 12, 1999
Method for treating patients having precancerous lesions with substituted indene derivatives
CELL PATHWAYS INC47 citations92
US5874440AFeb 23, 1999
Method of treating a patient having precancerous lesions with phenyl pyrimidinone derivatives
CELL PATHWAYS INC27 citations92
US5696159ADec 9, 1997
Lactone compounds for treating patients with precancerous lesions
CELL PATHWAYS INC35 citations92
US6025394AFeb 15, 2000
Method for treating patients with acne by administering substituted sulfonyl indenyl acetic acids, amides and alcohols
CELL PATHWAYS INC22 citations89
US6486158B1Nov 26, 2002
[4,5]-fused-3,6-disubstituted-pyridazines with sulfur-containing substituents in position three for the treatment of neoplasia
CELL PATHWAYS INC17 citations84
US6200771B1Mar 13, 2001
Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia
CELL PATHWAYS INC18 citations84
US6187779B1Feb 13, 2001
Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives
CELL PATHWAYS INC15 citations84
US6046199AApr 4, 2000
Method of inhibiting neoplastic cells with tetracyclic pyrido[3,4-B]indole derivatives
CELL PATHWAYS INC16 citations84
US6420410B1Jul 16, 2002
Method for treating neoplasia by exposure to N,N′-substituted benzimidazol-2-ones
CELL PATHWAYS INC17 citations83
US6166053ADec 26, 2000
Substituted condensation products of N-benzyl-3-idenylacetamides with heterocyclic aldehydes for neoplasia
CELL PATHWAYS INC14 citations81
US6562830B1May 13, 2003
Method of treating a patient having precancerous lesions with phenyl quinazolinone derivatives
CELL PATHWAYS INC8 citations74
US6403831B1Jun 11, 2002
Substituted benzylidene indenyl formamides, acetamides and propionamides
CELL PATHWAYS INC13 citations74
US6300346B1Oct 9, 2001
Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesions
CELL PATHWAYS INC7 citations74
US6211220B1Apr 3, 2001
Method for treating neoplasia with amino or pyridylamino cyclobutene derivatives
CELL PATHWAYS INC9 citations74
US6207666B1Mar 27, 2001
Method for treating a patient having precancerous lesion with 4-phenylphthalazine derivatives
CELL PATHWAYS INC9 citations74
US6124303ASep 26, 2000
Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones
CELL PATHWAYS INC8 citations74
US6060477AMay 9, 2000
Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives
CELL PATHWAYS INC15 citations74
US6046216AApr 4, 2000
Method of treating a patient having precancerous lesions with phenyl pyridinone derivatives
CELL PATHWAYS INC8 citations74
US6037345AMar 14, 2000
Method for inhibiting neoplastic cells and related conditions by exposure to quinazolinedione and pyridopyrimidinedione derivatives
CELL PATHWAYS INC15 citations74
US5998477ADec 7, 1999
Substituted methoxy benzylidene indenyl-acetic and propionic acids for treating patients with precancerous lesions
CELL PATHWAYS INC7 citations74
US5643959AJul 1, 1997
Method for treating patients with precancerous lesions by administering substituted sulfonyl indenyl acetic and propionic acids and esters thereof
CELL PATHWAYS INC17 citations74
US6359002B2Mar 19, 2002
Method for treating a patient with neoplasia by treatment with a platinum coordination complex
CELL PATHWAYS INC4 citations73
US6235776B1May 22, 2001
Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
CELL PATHWAYS INC12 citations73
US6066634AMay 23, 2000
Substituted condensation products of N-benzyl-3-indenylacetamides heterocyclic aldehydes for neoplasia
CELL PATHWAYS INC12 citations73
Showing the top 50 of 73 patents by PatentIndex Score.